Return to revision history
Revision as of 20:16:27, 5 November 2022 by 3.221.77.51
Revision as of 21:40:22, 14 December 2022 by 3.221.77.51
Line 1: Line 1:
This is especially important when the patient has relapsed disease, because the benefit of second line hormone manipulation is nearly 50, and failure to benefit from an initial trial with endocrine therapy correlates with second line failure <a href=http://nolvadex.one/>tamoxifen cost</a>
The editorialists, Timothy Lash, MD, PhD, and Carol Rosenberg, MD, from Boston University School of Health in Massachusetts, also noted that such testing is not recommended in any clinical guidelines, as reported by Medscape Oncology <a href=http://zithromax.one>azithromycin for std</a> Alternatively they may be administered in a pulsatile or continuous manner